<?xml version="1.0" ?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:media="http://search.yahoo.com/mrss/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:seo="http://purl.org/seo/elements/1.0/" version="2.0">
	<channel>
		<title>BioMed X Institute News Releases</title>
		<link>https://feeds.newsfilecorp.com/company/10612</link>
		<description>Latest news from BioMed X Institute, as distributed by TMX Newsfile.</description>
		<language>en</language>
		<copyright>CopyRight (c) 2026, Newsfile Corp. All Rights Reserved.</copyright>
		<managingEditor>office@newsfilecorp.com (Newsfile Corp.)</managingEditor>
		<webMaster>office@newsfilecorp.com (Newsfile Corp.)</webMaster>
		<lastBuildDate>Mon, 09 Mar 2026 18:38:18 -0400</lastBuildDate>
		<image>
			<url>https://www.newsfilecorp.com/images/newswire/customer-logos/10612.jpg</url>
			<title>BioMed X Institute News Releases</title>
			<link>https://feeds.newsfilecorp.com/company/10612</link>
		</image>
		<atom:link rel="self" type="application/rss+xml" href="https://feeds.newsfilecorp.com/company/10612"/>
		<item xml:lang="en">
			<title>BioMed X Start Collaboration in Autoimmunity Research with Servier</title>
			<link>https://www.newsfilecorp.com/release/214282/BioMed-X-Start-Collaboration-in-Autoimmunity-Research-with-Servier</link>
			<description>The new research team at the BioMed X Institute in Heidelberg will develop a novel strategy to selectively target autoreactive plasma cells in autoimmune disease.Heidelberg, Germany and Paris, France--(Newsfile Corp. - June 26, 2024) - BioMed X, an independent German biomedical research institute, and Servier, an international independent pharmaceutical company, announce the start of a new research team at the BioMed X Institute in Heidelberg to develop innovative strategies for neutralizing...&lt;img src="https://api.newsfilecorp.com/newsinfo/214282/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;</description>
			<pubDate>Wed, 26 Jun 2024 07:00:00 -0400</pubDate>
			<category domain="https://www.newsfilecorp.com/language">en</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/214282</guid>
		</item>
		<item xml:lang="en">
			<title>BioMed X Launches New US Institute in New Haven, CT</title>
			<link>https://www.newsfilecorp.com/release/212457/BioMed-X-Launches-New-US-Institute-in-New-Haven-CT</link>
			<description>Connecticut Governor Ned Lamont, New Haven Mayor Justin Elicker, and Josh Geballe, Managing Director of Yale Ventures, participated in the launch ceremony of the new BioMed X Institute on Tuesday, June 11, 2024. New Haven, Connecticut--(Newsfile Corp. - June 13, 2024) - BioMed X, an independent research institute founded in Heidelberg, Germany, has expanded its operations with the opening of a new institute in the United States. Located in New Haven, CT, in the vicinity of Yale University, the...&lt;img src="https://api.newsfilecorp.com/newsinfo/212457/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;</description>
			<pubDate>Thu, 13 Jun 2024 12:00:00 -0400</pubDate>
			<category domain="https://www.newsfilecorp.com/language">en</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/212457</guid>
		</item>
	</channel>
</rss>
